Latham & Watkins Advises Crossover Health in US$168 Million Series D Financing

An emerging companies team advises the tech-enabled, national healthcare organization in the transaction.

March 29, 2021

Crossover Health, a relationship-based, tech-enabled, national healthcare organization that integrates both virtual and in-person care for employers and health plans, has announced that it has raised US$168 million in an oversubscribed Series D financing led by Deerfield Management Company. Additional new investors include Perceptive Advisors, OrbiMed Advisors, Foresite Capital, Avidity Partners, SharesPost100 Fund, Irving Investors, and PFM Health Sciences. The capital will be applied to continuing the national expansion of Crossover's Connected System of Health for employers and payers.

Latham & Watkins LLP represents Crossover Health in the financing with an emerging companies team led by Bay Area partner Ben Potter, with Bay Area associates Chris Pham, Ajay Sundar, Kevin Cergol, and Erica Chae. Advice was also provided on benefits and compensation matters by Bay Area partner Ashley Wagner; and healthcare regulatory matters by Los Angeles partner Daniel Settelmayer and Washington, D.C. counsel Nicole Liffrig Molife.

 
 
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.